By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OpGen, Inc. 

505 South Rosa Road
Suite 151
Madison  Wisconsin  53719  U.S.A.
Phone: 608-441-8100 Fax:




Company News
OpGen (OPGN) Data On New Rapid Gene Test And Antibiotic Susceptibility Prediction Algorithms Presented At The 2017 ASM/ESCMID Conference 9/8/2017 8:16:32 AM
OpGen (OPGN) Reports 2017 Second Quarter Financial Results And Provides Business Update 8/9/2017 1:55:18 PM
OpGen (OPGN) Announces Date of Second Quarter 2017 Financial Results Conference Call 8/2/2017 1:19:48 PM
OpGen (OPGN) Announces Closing Of $10 Million Public Offering 7/19/2017 10:37:26 AM
OpGen (OPGN) Announces Pricing Of $10 Million Public Offering 7/13/2017 10:20:22 AM
OpGen (OPGN) Signs Supply Agreement To Use Thermo Fisher Scientific (TMO)'s Technology To Advance AcuitasĀ® Rapid Test 6/19/2017 9:05:05 AM
OpGen (OPGN) Announces 2017 First Quarter Financial Results 4/27/2017 12:14:40 PM
OpGen (OPGN) Appoints Tina S. Nova, Ph.D. To Board Of Directors 4/27/2017 10:30:45 AM
OpGen (OPGN) Highlights Capabilities Of Its Acuitas Technologies To Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles At ECCMID 4/25/2017 9:47:22 AM
OpGen (OPGN)Announces Date Of First Quarter 2017 Financial Results Conference Call 4/20/2017 10:26:38 AM